Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.48%.

  • Centessa Pharmaceuticals' Return on Capital Employed fell 1500.0% to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.49% for FY2024, which is 200.0% down from last year.
  • Centessa Pharmaceuticals' Return on Capital Employed amounted to 0.48% in Q3 2025, which was down 1500.0% from 0.43% recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.34% for Q3 2024, and its period low was 0.53% during Q1 2023.
  • Moreover, its 4-year median value for Return on Capital Employed was 0.49% (2024), whereas its average is 0.46%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 1700bps in 2024, then crashed by -1500bps in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.5% in 2022, then dropped by -4bps to 0.52% in 2023, then increased by 28bps to 0.38% in 2024, then fell by -29bps to 0.48% in 2025.
  • Its Return on Capital Employed stands at 0.48% for Q3 2025, versus 0.43% for Q2 2025 and 0.37% for Q1 2025.